Full Length Research Paper
References
Ademola E (2016). Barriers to uptake of prevention of mother-to-child transmission of HIV services among mothers of vertically infected HIV-seropositive infants in Nigeria. Patient Preference and Adherence pp. 57-72. |
|
Adeniyi ON, Ayayi AI, Goon DT, Owolabi EO, Eboh O, Lambert J (2018). Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa. BMC Infectious Disease 18:175. |
|
Agboeze J, Adedokun B, Adeoye I, Nwali M (2018). Determinants of adherence to antiretroviral therapy among women accessing prevention of mother to child transmission services in Ebonyi State, Nigeria. Pan African Medical Journal Conference Proceedings 2:248-253. |
|
Atalell KA, Birhan TN, Ekubagewargies DT (2018). Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study. PloS one 13(5):e0197145. |
|
Ekama S, Herbertson EC, Addeh EJ, Gad-Okafor CV, Onwujekwe DI, Tayo F, Ezechi OC (2012). Pattern and determinants of antiretroviral drugs adherence among Nigerian pregnant women. Journal of Pregnancy 3:21-30. |
|
Lubogo M, Bangure D, Lucas G, Sasita S, Justin M, Herilinda T, Theophil CM, Naod B (2014). Ebola virus disease outbreak the role of field epidemiology training programme in the fight against the epidemic, Liberia, 2014. The Pan African Medical Journal 22(Suppl 1):5. |
|
National Agency for Control of AIDS (NACA) (2018) Preventing Mother to child transmission of HIV in Nigeria. National Agency for Control of AIDS. |
|
National Agency for Control of AIDS (NACA) (2019). Revised National HIV and AIDS. |
|
National Population Commission (NPC) (2011). National Population Commission of Nigeria (Web). The Population Projection. |
|
Kalembo FW, Zgambo M (2012). Loss to followup: a major challenge to successful implementation of prevention of mother-to-child transmission of HIV-1 programs in sub-Saharan Africa. International Scholarly Research Notices 2012, Article ID 589817, 10 pages |
|
Oginni MO, Aremu OO, Olowokere AE, Ayamolowo SJ, Komolafe AO (2018). Adherence to HIV care among HIV-positive pregnant women in Nigeria. African Journal of Midwifery and Women's Health 12(1):28-34. |
|
Okoli JC, Lansdown GE (2014). Barriers to successful implementation of prevention-of-mother-to-child-transmission (PMTCT) of HIV programmes in Malawi and Nigeria: a critical literature review study. Pan African Medical Journal 19(1). |
|
Olowookere SA, Fatiregun AA, Adewole IF (2012). Knowledge and attitudes regarding HIV/AIDS and antiretroviral therapy among patients at a Nigerian treatment clinic. The Journal of Infection in Developing Countries 6(11):809-816. |
|
Omonaiye O, Kusljie S, Nicholson P, Mohebbi M, Manias E (2019). Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among preganat women with HIV. International Journal of Infectious Diseases 81:225-230. |
|
Owowo EE (2012). Treponema pallidum (Syphilis)-HIV/AIDS co-infections among Antenatal Women in South-South Region of Nigeria. International Journal of Natural and Applied Sciences 6(5):199-210. |
|
Owowo EE, Itah AY (2013). Prevalence of Enteric Fever-HIV/AIDS co-infections in Akwa Ibom State, Nigeria. World Journal of Natural and Applied Sciences 5(1):6-15. |
|
Lingala SM, Ghany MGM (2016). Implementation Research for the prevention of Mother to Child HIV transmission in Sub-Saharan: Existing Evidence. Current Gaps and New opportunities 23(3):289-313. |
|
Udofia LE, Udoh NB, Edohoabasi BG, Owowo EE (2022). Antimalarial Activity of Bambusa vulgaris on Plasmodium berghei in mice. Nigerian Journal of Parasitology 43(2):286-292. |
|
UNAIDS (2016). 2015-Prevention Gap Report, 76-80. |
|
UNAIDS (2019). AIDS info. |
|
WHO (2018). Knowing Your Status- Then and Now Table of World Health Organisation, December. |
|
Zacharius KM, Basinda N, Marwa K, Mtui EH, Kalolo A, Kapesa A (2019). Low adherence to Option B+ antiretroviral therapy among pregnant women and |
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0